All-Atom Models for the Non-Nucleoside Binding Site of HIV-1 Reverse Transcriptase Complexed with Inhibitors: A 3D QSAR Approach-Reference-Cited by-同舟云学术

All-Atom Models for the Non-Nucleoside Binding Site of HIV-1 Reverse Transcriptase Complexed with Inhibitors: A 3D QSAR Approach

Published:1996-01-01 Issue:8 Volume:39 Page:1645-1650
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Gussio Rick¹,Pattabiraman Nagarajan¹,Zaharevitz Daniel W.¹,Kellogg Glen E.¹,Topol Igor A.¹,Rice William G.¹,Schaeffer Catherine A.¹,Erickson John W.¹,Burt Stanley K.¹

Affiliation:

1. Frederick Biomedical Supercomputing Center, Structural Biochemistry Program, and Developmental Therapeutics Program, National Cancer Institute-FCRDC, SAIC Frederick, P.O. Box B, Frederick, Maryland 21702, and Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm9508088

Reference38 articles.

1. HIV-1-specific RT inhibitors: Highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase

2. Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

3. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relative assessment of different statistical instruments and measures for the prediction of promising outcomes using docking, virtual screening and ADMET analysis against HIV-RT;Journal of Biomolecular Structure and Dynamics;2021-03-29

2. HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: SAR and Lead Optimization Using CoMFA and CoMSIA Studies (1995-2016);Current Medicinal Chemistry;2017-11-17

3. Parallel screening of drug-like natural compounds using Caco-2 cell permeability QSAR model with applicability domain, lipophilic ligand efficiency index and shape property: A case study of HIV-1 reverse transcriptase inhibitors;Journal of Molecular Structure;2017-10

4. Integrated in Silico Methods for the Design and Optimization of Novel Drug Candidates;Oncology;2017

5. Integrated in Silico Methods for the Design and Optimization of Novel Drug Candidates;Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment;2015